What: Alex Taylor of Perelel and Kathryn Schubert of the Society for Women’s Health Research argue that investing in women’s health is not only a moral imperative, but also an economic one. They highlight that women are the primary healthcare decision-makers and spenders, controlling 80% of healthcare-buying decisions in the U.S. Despite this, only 2% of overall venture funding in health companies is directed toward women’s health startups.
Key line: “Those who signed our nonpartisan petition to Congress represent diverse backgrounds, experiences, and views. But we’re united in the idea that it shouldn’t take a decade to receive a diagnosis for a debilitating condition that impacts 1 in 10 women, like endometriosis; that when we’re pregnant and postpartum, basic access to obstetric care should be a given; and that women shouldn’t be more prone to treatment side effects simply because medications were only ever trialed on white men. As lawmakers continue to negotiate the federal budget, let’s join our voices and be clear: In 2025 and beyond, funding women’s health should no longer be up for debate.”
Source: Fast Company // https://www.fastcompany.com/91235810/why-funding-womens-health-shouldnt-be-up-for-debate